| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
CH:LONN
Lonza Group Ltd
|
Oct 30, 2026 | BUY |
Strong Buy
+1.2% avg upside
21 analysts
|
$770.00
19.54% Upside
|
+2.3% | Β· |
|
FR:IPN
Ipsen
|
Oct 29, 2026 | SELL |
Hold
-20.5% avg upside
17 analysts
|
$145.00
8.01% Downside
|
-0.7% | Β· |
|
DE:MRK
Merck KGaA
|
Oct 28, 2026 | HOLD |
Buy
-7.2% avg upside
34 analysts
|
$160.00
5.69% Upside
|
-1.0% | Β· |
|
DE:SRT3
Sartorius
|
Oct 23, 2026 | BUY |
Strong Buy
-0.2% avg upside
19 analysts
|
$320.00
9.73% Upside
|
+0.2% | Β· |
|
GB:0NZT
UCB SA
|
Oct 02, 2026 | HOLD |
Buy
-19.5% avg upside
19 analysts
|
$260.00
7.24% Downside
|
Β· | Β· |
|
FR:DIM
Sartorius Stedim Biotech
|
Sep 30, 2026 | BUY |
Strong Buy
+19.8% avg upside
12 analysts
|
$250.00
11.98% Upside
|
+9.5% | Β· |
|
DE:BAYN
Bayer
|
Sep 08, 2026 | BUY |
Buy
+8.7% avg upside
31 analysts
|
$70.00
38.45% Upside
|
+12.8% | Β· |
|
CH:PPGN
PolyPeptide Group AG
|
Sep 08, 2026 | HOLD |
Hold
-13.2% avg upside
3 analysts
|
$44.31
5.47% Upside
|
-8.3% | Β· |
|
CH:BANB
Bachem Holding AG
|
Sep 08, 2026 | HOLD |
Sell
-9.8% avg upside
4 analysts
|
$80.00
4.79% Downside
|
+3.4% | Β· |
|
IT:DIA
DiaSorin S.p.A.
|
Sep 07, 2026 | SELL |
Sell
+37.7% avg upside
10 analysts
|
$70.00
13.01% Downside
|
-12.2% | Β· |
|
FR:BIM
bioMerieux
|
Sep 07, 2026 | HOLD |
Buy
+15.3% avg upside
12 analysts
|
$80.00
11.53% Downside
|
+29.5% | Β· |
|
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
|
Jul 30, 2026 | HOLD |
Buy
-2.2% avg upside
9 analysts
|
$50.00
5.74% Downside
|
+2.8% | Β· |
|
ES:GRF
Grifols
|
Apr 22, 2026 | BUY |
Buy
+32.5% avg upside
13 analysts
|
$12.50
13.86% Upside
|
+28.3% | Β· |
|
CH:SDZ
Sandoz Group Ltd
|
Mar 11, 2026 | HOLD |
Buy
-14.9% avg upside
12 analysts
|
$75.00
8.90% Downside
|
+37.6% | Β· |
|
GB:DIA
Dialight
|
Jan 06, 2026 | SELL |
Strong Sell
1 analyst
|
β | -47.7% | Β· |
|
BAYRY
Bayer
|
Jan 06, 2026 | BUY |
Buy
+195.2% avg upside
9 analysts
|
β | +38.3% | Β· |
|
GB:0QW0
arGEN X
|
Oct 31, 2025 | BUY |
Strong Buy
-23.5% avg upside
25 analysts
|
$850.00
5.67% Upside
|
Β· | Β· |
|
ARGX
Argenx Se
|
Apr 28, 2025 | BUY |
Strong Buy
-8.2% avg upside
48 analysts
|
$728.37
18.47% Downside
|
+24.8% | Β· |
|
GRFS
Grifols SA
|
Jan 04, 2024 | BUY |
Buy
+179.5% avg upside
13 analysts
|
$20.17
148.93% Upside
|
-32.1% | Β· |
|
ABBV
AbbVie
|
Jan 13, 2022 | BUY |
Strong Buy
-14.5% avg upside
47 analysts
|
β | +15.0% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.